 | • レポートコード：MRC2-11QY10798 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は膜貫通型プロリル4ヒドロキシラーゼのグローバル市場について調査・分析したレポートです。種類別（ダプロダスタット、ジメチルオキサリルグリシン、FG-2216、FG-4497、その他）市場規模、用途別（貧血、炎症性腸疾患、脳浮腫、大腸炎、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別膜貫通型プロリル4ヒドロキシラーゼの競争状況、市場シェア ・世界の膜貫通型プロリル4ヒドロキシラーゼ市場：種類別市場規模 2015年-2020年（ダプロダスタット、ジメチルオキサリルグリシン、FG-2216、FG-4497、その他） ・世界の膜貫通型プロリル4ヒドロキシラーゼ市場：種類別市場規模予測 2021年-2026年（ダプロダスタット、ジメチルオキサリルグリシン、FG-2216、FG-4497、その他） ・世界の膜貫通型プロリル4ヒドロキシラーゼ市場：用途別市場規模 2015年-2020年（貧血、炎症性腸疾患、脳浮腫、大腸炎、その他） ・世界の膜貫通型プロリル4ヒドロキシラーゼ市場：用途別市場規模予測 2021年-2026年（貧血、炎症性腸疾患、脳浮腫、大腸炎、その他） ・北米の膜貫通型プロリル4ヒドロキシラーゼ市場分析：米国、カナダ ・ヨーロッパの膜貫通型プロリル4ヒドロキシラーゼ市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの膜貫通型プロリル4ヒドロキシラーゼ市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の膜貫通型プロリル4ヒドロキシラーゼ市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの膜貫通型プロリル4ヒドロキシラーゼ市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer AG、FibroGen Inc、GlaxoSmithKline Plc、Japan Tobacco Inc、Sigmoid Pharma Ltd、Merck & Co., Inc.、Akebia Therapeutics, Inc. ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Transmembrane Prolyl 4 Hydroxylase Market
The global Transmembrane Prolyl 4 Hydroxylase market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Transmembrane Prolyl 4 Hydroxylase Scope and Market Size
Transmembrane Prolyl 4 Hydroxylase market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Transmembrane Prolyl 4 Hydroxylase market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Transmembrane Prolyl 4 Hydroxylase market is segmented into
Daprodustat
Dimethyloxalylglycine
FG-2216
FG-4497
Others
Segment by Application, the Transmembrane Prolyl 4 Hydroxylase market is segmented into
Anemia
Inflammatory Bowel Disease
Brain Edema
Colitis
Others
Regional and Country-level Analysis
The Transmembrane Prolyl 4 Hydroxylase market is analysed and market size information is provided by regions (countries).
The key regions covered in the Transmembrane Prolyl 4 Hydroxylase market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Transmembrane Prolyl 4 Hydroxylase Market Share Analysis
Transmembrane Prolyl 4 Hydroxylase market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Transmembrane Prolyl 4 Hydroxylase business, the date to enter into the Transmembrane Prolyl 4 Hydroxylase market, Transmembrane Prolyl 4 Hydroxylase product introduction, recent developments, etc.
The major vendors covered:
Bayer AG
FibroGen Inc
GlaxoSmithKline Plc
Japan Tobacco Inc
Sigmoid Pharma Ltd
Merck & Co., Inc.
Akebia Therapeutics, Inc.
…
1 Study Coverage
1.1 Transmembrane Prolyl 4 Hydroxylase Product Introduction
1.2 Market Segments
1.3 Key Transmembrane Prolyl 4 Hydroxylase Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Transmembrane Prolyl 4 Hydroxylase Market Size Growth Rate by Type
1.4.2 Daprodustat
1.4.3 Dimethyloxalylglycine
1.4.4 FG-2216
1.4.5 FG-4497
1.4.6 Others
1.5 Market by Application
1.5.1 Global Transmembrane Prolyl 4 Hydroxylase Market Size Growth Rate by Application
1.5.2 Anemia
1.5.3 Inflammatory Bowel Disease
1.5.4 Brain Edema
1.5.5 Colitis
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Transmembrane Prolyl 4 Hydroxylase Market Size, Estimates and Forecasts
2.1.1 Global Transmembrane Prolyl 4 Hydroxylase Revenue 2015-2026
2.1.2 Global Transmembrane Prolyl 4 Hydroxylase Sales 2015-2026
2.2 Global Transmembrane Prolyl 4 Hydroxylase, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Transmembrane Prolyl 4 Hydroxylase Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Transmembrane Prolyl 4 Hydroxylase Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Transmembrane Prolyl 4 Hydroxylase Competitor Landscape by Players
3.1 Transmembrane Prolyl 4 Hydroxylase Sales by Manufacturers
3.1.1 Transmembrane Prolyl 4 Hydroxylase Sales by Manufacturers (2015-2020)
3.1.2 Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Manufacturers (2015-2020)
3.2 Transmembrane Prolyl 4 Hydroxylase Revenue by Manufacturers
3.2.1 Transmembrane Prolyl 4 Hydroxylase Revenue by Manufacturers (2015-2020)
3.2.2 Transmembrane Prolyl 4 Hydroxylase Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Transmembrane Prolyl 4 Hydroxylase Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Transmembrane Prolyl 4 Hydroxylase Revenue in 2019
3.2.5 Global Transmembrane Prolyl 4 Hydroxylase Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Transmembrane Prolyl 4 Hydroxylase Price by Manufacturers
3.4 Transmembrane Prolyl 4 Hydroxylase Manufacturing Base Distribution, Product Types
3.4.1 Transmembrane Prolyl 4 Hydroxylase Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Transmembrane Prolyl 4 Hydroxylase Product Type
3.4.3 Date of International Manufacturers Enter into Transmembrane Prolyl 4 Hydroxylase Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Transmembrane Prolyl 4 Hydroxylase Market Size by Type (2015-2020)
4.1.1 Global Transmembrane Prolyl 4 Hydroxylase Sales by Type (2015-2020)
4.1.2 Global Transmembrane Prolyl 4 Hydroxylase Revenue by Type (2015-2020)
4.1.3 Transmembrane Prolyl 4 Hydroxylase Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Transmembrane Prolyl 4 Hydroxylase Market Size Forecast by Type (2021-2026)
4.2.1 Global Transmembrane Prolyl 4 Hydroxylase Sales Forecast by Type (2021-2026)
4.2.2 Global Transmembrane Prolyl 4 Hydroxylase Revenue Forecast by Type (2021-2026)
4.2.3 Transmembrane Prolyl 4 Hydroxylase Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Transmembrane Prolyl 4 Hydroxylase Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Transmembrane Prolyl 4 Hydroxylase Market Size by Application (2015-2020)
5.1.1 Global Transmembrane Prolyl 4 Hydroxylase Sales by Application (2015-2020)
5.1.2 Global Transmembrane Prolyl 4 Hydroxylase Revenue by Application (2015-2020)
5.1.3 Transmembrane Prolyl 4 Hydroxylase Price by Application (2015-2020)
5.2 Transmembrane Prolyl 4 Hydroxylase Market Size Forecast by Application (2021-2026)
5.2.1 Global Transmembrane Prolyl 4 Hydroxylase Sales Forecast by Application (2021-2026)
5.2.2 Global Transmembrane Prolyl 4 Hydroxylase Revenue Forecast by Application (2021-2026)
5.2.3 Global Transmembrane Prolyl 4 Hydroxylase Price Forecast by Application (2021-2026)
6 North America
6.1 North America Transmembrane Prolyl 4 Hydroxylase by Country
6.1.1 North America Transmembrane Prolyl 4 Hydroxylase Sales by Country
6.1.2 North America Transmembrane Prolyl 4 Hydroxylase Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Transmembrane Prolyl 4 Hydroxylase Market Facts & Figures by Type
6.3 North America Transmembrane Prolyl 4 Hydroxylase Market Facts & Figures by Application
7 Europe
7.1 Europe Transmembrane Prolyl 4 Hydroxylase by Country
7.1.1 Europe Transmembrane Prolyl 4 Hydroxylase Sales by Country
7.1.2 Europe Transmembrane Prolyl 4 Hydroxylase Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Transmembrane Prolyl 4 Hydroxylase Market Facts & Figures by Type
7.3 Europe Transmembrane Prolyl 4 Hydroxylase Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Transmembrane Prolyl 4 Hydroxylase by Region
8.1.1 Asia Pacific Transmembrane Prolyl 4 Hydroxylase Sales by Region
8.1.2 Asia Pacific Transmembrane Prolyl 4 Hydroxylase Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Transmembrane Prolyl 4 Hydroxylase Market Facts & Figures by Type
8.3 Asia Pacific Transmembrane Prolyl 4 Hydroxylase Market Facts & Figures by Application
9 Latin America
9.1 Latin America Transmembrane Prolyl 4 Hydroxylase by Country
9.1.1 Latin America Transmembrane Prolyl 4 Hydroxylase Sales by Country
9.1.2 Latin America Transmembrane Prolyl 4 Hydroxylase Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Transmembrane Prolyl 4 Hydroxylase Market Facts & Figures by Type
9.3 Central & South America Transmembrane Prolyl 4 Hydroxylase Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Transmembrane Prolyl 4 Hydroxylase by Country
10.1.1 Middle East and Africa Transmembrane Prolyl 4 Hydroxylase Sales by Country
10.1.2 Middle East and Africa Transmembrane Prolyl 4 Hydroxylase Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Transmembrane Prolyl 4 Hydroxylase Market Facts & Figures by Type
10.3 Middle East and Africa Transmembrane Prolyl 4 Hydroxylase Market Facts & Figures by Application
11 Company Profiles
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Description and Business Overview
11.1.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer AG Transmembrane Prolyl 4 Hydroxylase Products Offered
11.1.5 Bayer AG Related Developments
11.2 FibroGen Inc
11.2.1 FibroGen Inc Corporation Information
11.2.2 FibroGen Inc Description and Business Overview
11.2.3 FibroGen Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 FibroGen Inc Transmembrane Prolyl 4 Hydroxylase Products Offered
11.2.5 FibroGen Inc Related Developments
11.3 GlaxoSmithKline Plc
11.3.1 GlaxoSmithKline Plc Corporation Information
11.3.2 GlaxoSmithKline Plc Description and Business Overview
11.3.3 GlaxoSmithKline Plc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline Plc Transmembrane Prolyl 4 Hydroxylase Products Offered
11.3.5 GlaxoSmithKline Plc Related Developments
11.4 Japan Tobacco Inc
11.4.1 Japan Tobacco Inc Corporation Information
11.4.2 Japan Tobacco Inc Description and Business Overview
11.4.3 Japan Tobacco Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Japan Tobacco Inc Transmembrane Prolyl 4 Hydroxylase Products Offered
11.4.5 Japan Tobacco Inc Related Developments
11.5 Sigmoid Pharma Ltd
11.5.1 Sigmoid Pharma Ltd Corporation Information
11.5.2 Sigmoid Pharma Ltd Description and Business Overview
11.5.3 Sigmoid Pharma Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sigmoid Pharma Ltd Transmembrane Prolyl 4 Hydroxylase Products Offered
11.5.5 Sigmoid Pharma Ltd Related Developments
11.6 Merck & Co., Inc.
11.6.1 Merck & Co., Inc. Corporation Information
11.6.2 Merck & Co., Inc. Description and Business Overview
11.6.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Merck & Co., Inc. Transmembrane Prolyl 4 Hydroxylase Products Offered
11.6.5 Merck & Co., Inc. Related Developments
11.7 Akebia Therapeutics, Inc.
11.7.1 Akebia Therapeutics, Inc. Corporation Information
11.7.2 Akebia Therapeutics, Inc. Description and Business Overview
11.7.3 Akebia Therapeutics, Inc. Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Akebia Therapeutics, Inc. Transmembrane Prolyl 4 Hydroxylase Products Offered
11.7.5 Akebia Therapeutics, Inc. Related Developments
11.1 Bayer AG
11.1.1 Bayer AG Corporation Information
11.1.2 Bayer AG Description and Business Overview
11.1.3 Bayer AG Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer AG Transmembrane Prolyl 4 Hydroxylase Products Offered
11.1.5 Bayer AG Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Transmembrane Prolyl 4 Hydroxylase Market Estimates and Projections by Region
12.1.1 Global Transmembrane Prolyl 4 Hydroxylase Sales Forecast by Regions 2021-2026
12.1.2 Global Transmembrane Prolyl 4 Hydroxylase Revenue Forecast by Regions 2021-2026
12.2 North America Transmembrane Prolyl 4 Hydroxylase Market Size Forecast (2021-2026)
12.2.1 North America: Transmembrane Prolyl 4 Hydroxylase Sales Forecast (2021-2026)
12.2.2 North America: Transmembrane Prolyl 4 Hydroxylase Revenue Forecast (2021-2026)
12.2.3 North America: Transmembrane Prolyl 4 Hydroxylase Market Size Forecast by Country (2021-2026)
12.3 Europe Transmembrane Prolyl 4 Hydroxylase Market Size Forecast (2021-2026)
12.3.1 Europe: Transmembrane Prolyl 4 Hydroxylase Sales Forecast (2021-2026)
12.3.2 Europe: Transmembrane Prolyl 4 Hydroxylase Revenue Forecast (2021-2026)
12.3.3 Europe: Transmembrane Prolyl 4 Hydroxylase Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Transmembrane Prolyl 4 Hydroxylase Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Transmembrane Prolyl 4 Hydroxylase Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Transmembrane Prolyl 4 Hydroxylase Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Transmembrane Prolyl 4 Hydroxylase Market Size Forecast by Region (2021-2026)
12.5 Latin America Transmembrane Prolyl 4 Hydroxylase Market Size Forecast (2021-2026)
12.5.1 Latin America: Transmembrane Prolyl 4 Hydroxylase Sales Forecast (2021-2026)
12.5.2 Latin America: Transmembrane Prolyl 4 Hydroxylase Revenue Forecast (2021-2026)
12.5.3 Latin America: Transmembrane Prolyl 4 Hydroxylase Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Transmembrane Prolyl 4 Hydroxylase Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Transmembrane Prolyl 4 Hydroxylase Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Transmembrane Prolyl 4 Hydroxylase Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Transmembrane Prolyl 4 Hydroxylase Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Transmembrane Prolyl 4 Hydroxylase Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Transmembrane Prolyl 4 Hydroxylase Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Transmembrane Prolyl 4 Hydroxylase Market Segments
Table 2. Ranking of Global Top Transmembrane Prolyl 4 Hydroxylase Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Transmembrane Prolyl 4 Hydroxylase Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Daprodustat
Table 5. Major Manufacturers of Dimethyloxalylglycine
Table 6. Major Manufacturers of FG-2216
Table 7. Major Manufacturers of FG-4497
Table 8. Major Manufacturers of Others
Table 9. Global Transmembrane Prolyl 4 Hydroxylase Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Transmembrane Prolyl 4 Hydroxylase Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Transmembrane Prolyl 4 Hydroxylase Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Regions (2015-2020)
Table 13. Global Transmembrane Prolyl 4 Hydroxylase Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Transmembrane Prolyl 4 Hydroxylase Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Transmembrane Prolyl 4 Hydroxylase Sales Share by Manufacturers (2015-2020)
Table 16. Global Transmembrane Prolyl 4 Hydroxylase Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Transmembrane Prolyl 4 Hydroxylase by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transmembrane Prolyl 4 Hydroxylase as of 2019)
Table 18. Transmembrane Prolyl 4 Hydroxylase Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Transmembrane Prolyl 4 Hydroxylase Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Transmembrane Prolyl 4 Hydroxylase Price (2015-2020) (USD/Pcs)
Table 21. Transmembrane Prolyl 4 Hydroxylase Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Transmembrane Prolyl 4 Hydroxylase Product Type
Table 23. Date of International Manufacturers Enter into Transmembrane Prolyl 4 Hydroxylase Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Transmembrane Prolyl 4 Hydroxylase Sales by Type (2015-2020) (K Pcs)
Table 26. Global Transmembrane Prolyl 4 Hydroxylase Sales Share by Type (2015-2020)
Table 27. Global Transmembrane Prolyl 4 Hydroxylase Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Transmembrane Prolyl 4 Hydroxylase Revenue Share by Type (2015-2020)
Table 29. Transmembrane Prolyl 4 Hydroxylase Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Transmembrane Prolyl 4 Hydroxylase Sales by Application (2015-2020) (K Pcs)
Table 31. Global Transmembrane Prolyl 4 Hydroxylase Sales Share by Application (2015-2020)
Table 32. North America Transmembrane Prolyl 4 Hydroxylase Sales by Country (2015-2020) (K Pcs)
Table 33. North America Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Country (2015-2020)
Table 34. North America Transmembrane Prolyl 4 Hydroxylase Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Transmembrane Prolyl 4 Hydroxylase Revenue Market Share by Country (2015-2020)
Table 36. North America Transmembrane Prolyl 4 Hydroxylase Sales by Type (2015-2020) (K Pcs)
Table 37. North America Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Type (2015-2020)
Table 38. North America Transmembrane Prolyl 4 Hydroxylase Sales by Application (2015-2020) (K Pcs)
Table 39. North America Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Application (2015-2020)
Table 40. Europe Transmembrane Prolyl 4 Hydroxylase Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Country (2015-2020)
Table 42. Europe Transmembrane Prolyl 4 Hydroxylase Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Transmembrane Prolyl 4 Hydroxylase Revenue Market Share by Country (2015-2020)
Table 44. Europe Transmembrane Prolyl 4 Hydroxylase Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Type (2015-2020)
Table 46. Europe Transmembrane Prolyl 4 Hydroxylase Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Transmembrane Prolyl 4 Hydroxylase Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Transmembrane Prolyl 4 Hydroxylase Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Transmembrane Prolyl 4 Hydroxylase Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Transmembrane Prolyl 4 Hydroxylase Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Transmembrane Prolyl 4 Hydroxylase Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Application (2015-2020)
Table 56. Latin America Transmembrane Prolyl 4 Hydroxylase Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Transmembrane Prolyl 4 Hydroxylase Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Transmembrane Prolyl 4 Hydroxylase Revenue Market Share by Country (2015-2020)
Table 60. Latin America Transmembrane Prolyl 4 Hydroxylase Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Type (2015-2020)
Table 62. Latin America Transmembrane Prolyl 4 Hydroxylase Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Transmembrane Prolyl 4 Hydroxylase Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Transmembrane Prolyl 4 Hydroxylase Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Transmembrane Prolyl 4 Hydroxylase Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Transmembrane Prolyl 4 Hydroxylase Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Transmembrane Prolyl 4 Hydroxylase Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Application (2015-2020)
Table 72. Bayer AG Corporation Information
Table 73. Bayer AG Description and Major Businesses
Table 74. Bayer AG Transmembrane Prolyl 4 Hydroxylase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Bayer AG Product
Table 76. Bayer AG Recent Development
Table 77. FibroGen Inc Corporation Information
Table 78. FibroGen Inc Description and Major Businesses
Table 79. FibroGen Inc Transmembrane Prolyl 4 Hydroxylase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. FibroGen Inc Product
Table 81. FibroGen Inc Recent Development
Table 82. GlaxoSmithKline Plc Corporation Information
Table 83. GlaxoSmithKline Plc Description and Major Businesses
Table 84. GlaxoSmithKline Plc Transmembrane Prolyl 4 Hydroxylase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. GlaxoSmithKline Plc Product
Table 86. GlaxoSmithKline Plc Recent Development
Table 87. Japan Tobacco Inc Corporation Information
Table 88. Japan Tobacco Inc Description and Major Businesses
Table 89. Japan Tobacco Inc Transmembrane Prolyl 4 Hydroxylase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Japan Tobacco Inc Product
Table 91. Japan Tobacco Inc Recent Development
Table 92. Sigmoid Pharma Ltd Corporation Information
Table 93. Sigmoid Pharma Ltd Description and Major Businesses
Table 94. Sigmoid Pharma Ltd Transmembrane Prolyl 4 Hydroxylase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Sigmoid Pharma Ltd Product
Table 96. Sigmoid Pharma Ltd Recent Development
Table 97. Merck & Co., Inc. Corporation Information
Table 98. Merck & Co., Inc. Description and Major Businesses
Table 99. Merck & Co., Inc. Transmembrane Prolyl 4 Hydroxylase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Merck & Co., Inc. Product
Table 101. Merck & Co., Inc. Recent Development
Table 102. Akebia Therapeutics, Inc. Corporation Information
Table 103. Akebia Therapeutics, Inc. Description and Major Businesses
Table 104. Akebia Therapeutics, Inc. Transmembrane Prolyl 4 Hydroxylase Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. Akebia Therapeutics, Inc. Product
Table 106. Akebia Therapeutics, Inc. Recent Development
Table 107. Global Transmembrane Prolyl 4 Hydroxylase Sales Forecast by Regions (2021-2026) (K Pcs)
Table 108. Global Transmembrane Prolyl 4 Hydroxylase Sales Market Share Forecast by Regions (2021-2026)
Table 109. Global Transmembrane Prolyl 4 Hydroxylase Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 110. Global Transmembrane Prolyl 4 Hydroxylase Revenue Market Share Forecast by Regions (2021-2026)
Table 111. North America: Transmembrane Prolyl 4 Hydroxylase Sales Forecast by Country (2021-2026) (K Pcs)
Table 112. North America: Transmembrane Prolyl 4 Hydroxylase Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Europe: Transmembrane Prolyl 4 Hydroxylase Sales Forecast by Country (2021-2026) (K Pcs)
Table 114. Europe: Transmembrane Prolyl 4 Hydroxylase Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Asia Pacific: Transmembrane Prolyl 4 Hydroxylase Sales Forecast by Region (2021-2026) (K Pcs)
Table 116. Asia Pacific: Transmembrane Prolyl 4 Hydroxylase Revenue Forecast by Region (2021-2026) (US$ Million)
Table 117. Latin America: Transmembrane Prolyl 4 Hydroxylase Sales Forecast by Country (2021-2026) (K Pcs)
Table 118. Latin America: Transmembrane Prolyl 4 Hydroxylase Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Middle East and Africa: Transmembrane Prolyl 4 Hydroxylase Sales Forecast by Country (2021-2026) (K Pcs)
Table 120. Middle East and Africa: Transmembrane Prolyl 4 Hydroxylase Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 122. Key Challenges
Table 123. Market Risks
Table 124. Main Points Interviewed from Key Transmembrane Prolyl 4 Hydroxylase Players
Table 125. Transmembrane Prolyl 4 Hydroxylase Customers List
Table 126. Transmembrane Prolyl 4 Hydroxylase Distributors List
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Transmembrane Prolyl 4 Hydroxylase Product Picture
Figure 2. Global Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Type in 2020 & 2026
Figure 3. Daprodustat Product Picture
Figure 4. Dimethyloxalylglycine Product Picture
Figure 5. FG-2216 Product Picture
Figure 6. FG-4497 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Application in 2020 & 2026
Figure 9. Anemia
Figure 10. Inflammatory Bowel Disease
Figure 11. Brain Edema
Figure 12. Colitis
Figure 13. Others
Figure 14. Transmembrane Prolyl 4 Hydroxylase Report Years Considered
Figure 15. Global Transmembrane Prolyl 4 Hydroxylase Market Size 2015-2026 (US$ Million)
Figure 16. Global Transmembrane Prolyl 4 Hydroxylase Sales 2015-2026 (K Pcs)
Figure 17. Global Transmembrane Prolyl 4 Hydroxylase Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Region (2015-2020)
Figure 19. Global Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Region in 2019
Figure 20. Global Transmembrane Prolyl 4 Hydroxylase Revenue Market Share by Region (2015-2020)
Figure 21. Global Transmembrane Prolyl 4 Hydroxylase Revenue Market Share by Region in 2019
Figure 22. Global Transmembrane Prolyl 4 Hydroxylase Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Transmembrane Prolyl 4 Hydroxylase Revenue in 2019
Figure 24. Transmembrane Prolyl 4 Hydroxylase Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Type (2015-2020)
Figure 26. Global Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Type in 2019
Figure 27. Global Transmembrane Prolyl 4 Hydroxylase Revenue Market Share by Type (2015-2020)
Figure 28. Global Transmembrane Prolyl 4 Hydroxylase Revenue Market Share by Type in 2019
Figure 29. Global Transmembrane Prolyl 4 Hydroxylase Market Share by Price Range (2015-2020)
Figure 30. Global Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Application (2015-2020)
Figure 31. Global Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Application in 2019
Figure 32. Global Transmembrane Prolyl 4 Hydroxylase Revenue Market Share by Application (2015-2020)
Figure 33. Global Transmembrane Prolyl 4 Hydroxylase Revenue Market Share by Application in 2019
Figure 34. North America Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Country in 2019
Figure 37. North America Transmembrane Prolyl 4 Hydroxylase Revenue Market Share by Country in 2019
Figure 38. U.S. Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Transmembrane Prolyl 4 Hydroxylase Market Share by Type in 2019
Figure 43. North America Transmembrane Prolyl 4 Hydroxylase Market Share by Application in 2019
Figure 44. Europe Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Country in 2019
Figure 47. Europe Transmembrane Prolyl 4 Hydroxylase Revenue Market Share by Country in 2019
Figure 48. Germany Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Transmembrane Prolyl 4 Hydroxylase Market Share by Type in 2019
Figure 59. Europe Transmembrane Prolyl 4 Hydroxylase Market Share by Application in 2019
Figure 60. Asia Pacific Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Region in 2019
Figure 63. Asia Pacific Transmembrane Prolyl 4 Hydroxylase Revenue Market Share by Region in 2019
Figure 64. China Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Transmembrane Prolyl 4 Hydroxylase Market Share by Type in 2019
Figure 87. Asia Pacific Transmembrane Prolyl 4 Hydroxylase Market Share by Application in 2019
Figure 88. Latin America Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Country in 2019
Figure 91. Latin America Transmembrane Prolyl 4 Hydroxylase Revenue Market Share by Country in 2019
Figure 92. Mexico Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Transmembrane Prolyl 4 Hydroxylase Market Share by Type in 2019
Figure 99. Latin America Transmembrane Prolyl 4 Hydroxylase Market Share by Application in 2019
Figure 100. Middle East and Africa Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Transmembrane Prolyl 4 Hydroxylase Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Transmembrane Prolyl 4 Hydroxylase Revenue Market Share by Country in 2019
Figure 104. Turkey Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Transmembrane Prolyl 4 Hydroxylase Market Share by Type in 2019
Figure 111. Middle East and Africa Transmembrane Prolyl 4 Hydroxylase Market Share by Application in 2019
Figure 112. North America Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Transmembrane Prolyl 4 Hydroxylase Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Transmembrane Prolyl 4 Hydroxylase Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
チロシンヒドロキシラーゼ欠損症治療薬の世界市場（～2026年） The Tyrosine Hydroxylase Deficiency is also known as recessive dopa-responsive dystonia and is a rare genetic disorder. In the Tyrosine Hydroxylase Deficiency, there is lack of enzymes which are involved in converting amino acid tyrosine to L-dopa. A wide range of symptoms can be associated with the…- チロシンヒドロキシラーゼ欠損症治療の世界市場（～2026年） The Tyrosine Hydroxylase Deficiency is also known as recessive dopa-responsive dystonia and is a rare genetic disorder. In the Tyrosine Hydroxylase Deficiency, there is lack of enzymes which are involved in converting amino acid tyrosine to L-dopa. A wide range of symptoms can be associated with the…
- 貧血治療薬の世界市場（～2026年） Anemia is a disease in which the blood does not carry the optimal amount of oxygen due to red blood cell count or a severe reduction, in our report, it studies iron deficiency anemia, sickle cell anemia, pernicious anemia, hemolytic anemia. The iron deficiency anemia market segment accounted for the…
- 化学療法誘発性貧血（CIA）の世界市場（～2026年） Anaemia is a frequent complication of malignancy and is aggravated by chemotherapy. The key factor contributing to the growth of the global chemotherapy induced anemia market is the increase in the occurrence of cancer and anemia among geriatric patients. Market Analysis and Insights: Global Chemoth…
- 鎌状赤血球貧血治療薬の世界市場（～2026年） Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…